A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain

Summary

CE-224535 is a new medication being developed as an analgesic and anti-inflammatory agent for the treatment of the signs and symptoms of osteoarthritis (OA). The purpose of this study is to evaluate the analgesic and anti inflammatory efficacy and safety of CE 224,535 versus placebo and naproxen treatment in patients with OA knee pain.

Timeline

Start

2007-01

Primary completion

—

Completion

2007-08

Drugs

Indications